6,6,9-TRIFLUORO-11,21-DIHYDROXY-16,17-((1-METHYLETHYLIDENE)BIS(OXY))PREGNA-1,4-DIENE-3,20-DIONE, (11.BETA.,16.ALPHA.)-
UNII 4BV2X3C16V
Substance Identification & Data
This profile provides standardized clinical and technical data for 6,6,9-trifluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))pregna-1,4-diene-3,20-dione, (11.beta.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4BV2X3C16V.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 37502-41-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H29F3O6 VOJVXZSJCOZWNA-ZGMGFCDJSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6,6,9-trifluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))pregna-1,4-diene-3,20-dione, (11.beta.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.